Novamex USA Ltd Announces the Results From the Canadian Food Inspection Agency.

Business Editors & Health/Medical Writers

BIOWIRE2K

MONTREAL--(BW HealthWire)--May 10, 2002

Novamex USA Ltd (the "Company") (NQB Pink Sheets:NOVM) a development stage company which develops and manufactures bacteria and virus detection kits mainly for non-clinical industry segments including the agri-food and veterinary segments today announced that its Novascreen Salmonella ELISA spot test has passed the Microbiological Methods Committee (MMC) statistical criteria of the Canadian Food Inspection Agency.

As a result, it will be assigned a Laboratory Procedure MFLP number and placed in the Official Compendium of Analytical Methods, Volume 3, Laboratory Procedures for the Microbiological Analysis of Foods. This will allow the Company to produce, market and sell the test kit which will then generate cash to be used toward the development of other test kits and to expand the Company's client base in North and South America, Europe and Asia.

"We believe that these results are the first building blocks of the commercial success of our enterprise and will contribute to the ongoing sales and marketing efforts of the Company," stated Mr. Karim Menassa, president of Novamex USA Ltd.

The Novascreen Salmonella ELISA spot test is one of many rapid test kits developed and manufactured by the Company. Other test have been or will be submitted to governmental agencies including the E.Coli test kit, the listeria test kit and the general hygiene test kit.

About the Novascreen Salmonella ELISA spot test, in order to detect Salmonella in food, the Company uses a proprietary antigen/antibody reaction technology whereby any detectible reaction takes place entirely inside a plastic cassette which is part of the test kit. The test also has the benefit of rapid diagnostic test methods such as the absence of incubation or washing steps. The results of the test can be read visually using a colorimetric reaction and can be known within approximately 15 minutes. The Company's tests are timely, affordable and do not compromise on accuracy.

Salmonella, which is generally found in poultry and eggs, may cause serious gastro-enteritis in humans and may be responsible for 60% to 80% of all cases of food-borne infection or intoxication throughout the world.

About the Company, Novamex USA Ltd is a development stage biotechnology Company specialized in the development and manufacturing of rapid detection test kits mainly for non-clinical industry segments including the agri-food and veterinary segments.

This release may include forward-looking statements with respect to business plans, activities, prospects, opportunities and events anticipated or being pursued by the Company. The realization of the outcomes referred to in such statements involves a number of risks and uncertainties, including but not limited to: decisions, or the timing of decisions, made by third parties over which the Company has little or no control or influence; the level of interest of customers, employees, suppliers and investors in the Company and its markets, products and prospects; the availability of funding for customer purchases and financing for the Company; changes in economic and market conditions, industry standards, and government laws and regulations; as well as other risk factors detailed in the securities filings of the Company to which recipients of this release are referred for additional information concerning the Company and its prospects.